- 08/10/2019 - 31/05/2022
- Natalia Rakislova
- Bill & Melinda Gates Foundation
The MIBio project (INV-002394) is coordinated by the Barcelona Institute of Global Health (ISGlobal) and is carried out in collaboration with the Faculty of Medicine of Eduardo Mondlane University (UEM, Mozambique), the Maputo Central Hospital (MCH, Mozambique), the Manhiça Health Research Center/Fundação Manhiça (CISM/FM, Mozambique) and Hospital Clínic of Barcelona (FCRB, Spain).
The overall goal of the MIBio project is to potentially reduce maternal and perinatal morbidity and mortality associated with preterm birth and/or preeclampsia in a low-resource setting by improving the accuracy of postmortem identification of these conditions. Minimally Invasive Tissue Sampling (MITS) enriched with the determination of angiogenic biomarkers and post-mortem ultrasound could serve as a perinatal mortality surveillance tool in geographic areas with a high burden of pregnancy-related hypertensive disorders and prematurity.
Additionally, the project also aims at contributing to the capacity building of young African researchers and establishing sustainable networks to tackle preeclampsia and prematurity.
Otros proyectosVer proyectos pasados
Validación continuada de la autopsia mínimamente invasiva (MIA) para la investigación de la causa de muerte en niños pequeños, y desarrollo de un centro de investigación y formación sobre el estudio de la causa de muerte
Transforming IPT for optimal pregnancy
Measuring community prevalence among HIV exposed children in rural Southern Mozambique
Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women
Improving Care through Azithromycin Research for Infants in Africa